Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does ...
Read moreDetailsFor patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info